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Human African trypanosomiasis is a devastating disease with only a few treatment options, including pentam-
idine. Diamidine compounds such as pentamidine, DB75, and DB820 are potent antitrypanosomal compounds.
Previous investigations have shown that diamidines accumulate to high concentrations in trypanosomes. However,
the mechanism of action of this class of compounds remains unknown. A long-hypothesized mechanism of action
has been binding to DNA and interference with DNA-associated enzymes. The fluorescent diamidines, DB75 and
DB820, have been shown to localize not only in the DNA-containing nucleus and kinetoplast of trypanosomes but
also to the acidocalcisomes. Here we investigate two series of analogs of DB75 and DB820 with various levels of in
vitro antitrypanosomal activity to determine whether any correlation exists between trypanosome accumulation,
distribution, and in vitro activity. Despite wide ranges of in vitro antitrypanosomal activity, all of the compounds
investigated accumulated to millimolar concentrations in trypanosomes over a period of 8 h. Interestingly, some of
the less potent compounds accumulated to concentrations much higher than those of more potent compounds. All
of the compounds were localized to the DNA-containing nucleus and/or kinetoplast, and many were also found in
the acidocalcisomes. Accumulation in the nucleus and kinetoplast should be important to the mechanism of action
of these compounds. The acidocalcisomes may also play a role in the mechanism of action of these compounds. This
investigation suggests that the extent of accumulation alone is not responsible for killing trypanosomes and that
organelle-specific accumulation may not predict in vitro activity.
Diamidine compounds, such as pentamidine, propamidine,
and diminazene, have been used for many years as chemother-
apeutic agents for infections caused by a variety of microbes,
including parasites and fungi. Pentamidine has been used for
almost 60 years as a treatment for human African trypanoso-
miasis and is also used to treat leishmaniasis and the oppor-
tunistic infection Pneumocystis pneumonia (32). Diminazene
has been used widely for treatment of animal trypanosomiasis
(9) and has also been used in humans (25). Recently, pafura-
midine, or DB289, a methamidoxime prodrug of the diamidine
DB75 (furamidine), has been developed as an oral treatment
for early-stage sleeping sickness caused by Trypanosoma brucei
gambiense. DB289 is currently in phase III clinical trials in
sub-Saharan Africa (6). In addition to DB75 and DB289, a
library of diamidines and prodrugs has been synthesized, with
various activities against many parasites (1–3, 14–18, 32).
Although diamidines have been used therapeutically for over
half a century, their mechanism of action is not well understood.
Many mechanisms of action have been proposed (32), but one
mechanism of action of diamidines that has often been hypothe-
sized is binding to DNA in the nucleus or kinetoplast, leading to
interference of DNA-associated enzymes, such as topoisomerase
II (27, 34). Pentamidine has also been shown to linearize kineto-
plast DNA isolated from trypanosomes (27), which could play an
important role in the compound’s mechanism of action. Further-
more, ultrastructural studies of whole trypanosomes have dem-
onstrated that diamidines such as pentamidine have an impact on
the kinetoplasts of trypanosomes, perhaps leading to the disinte-
gration of kinetoplast DNA (33). However, neither quantitative
nor qualitative investigations have been performed to determine
in which compartments pentamidine localizes in trypanosomes.
This is not surprising, as pentamidine is not a fluorescent com-
pound and therefore its intracellular distribution cannot be
tracked using microscopy.
Several innately fluorescent compounds related to pentam-
idine have been investigated qualitatively in cancer cells (19,
20) to determine effects of structural modifications on nuclear
distribution. Compounds tested included DB75, the substi-
tuted diamidines DB569, DB244, and DB249, and the imidaz-
oline DB60 (Fig. 1). Lansiaux et al. found that of the three
substituted diamidines, only the N-phenyl-substituted com-
pound DB569 had an altered distribution in cells. While the
other compounds were localized to the nuclei of cancer cells,
DB569 was found only in the mitochondria (20).
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More recently, the accumulation and distribution in trypano-
somes of two fluorescent analogs of pentamidine, namely,
DB75 and its aza analog, DB820, were described (24). Both
compounds accumulated within trypanosomes to millimolar
concentrations both in vitro and in an in vivo mouse model,
with concentrations in trypanosomes approximately 1000-fold
or greater than the environmental concentrations. These com-
pounds not only were distributed in the nucleus and kineto-
plast, the DNA-containing organelles of trypanosomes, but
were also found to be localized to acidocalcisomes. Although
DNA binding has been hypothesized to be the mechanism of
action for diamidines, accumulation in the acidocalcisomes or
other organelles may also play an important role in killing
these parasites.
This paper describes the in vitro activity, DNA binding abil-
ity, accumulation, and cellular distribution of 13 structurally
related compounds. Because some are intensely fluorescent
and others are not as fluorescent, we combined qualitative
microscopy studies to determine the intracellular localization
of the compounds with quantitative high-pressure liquid chro-
matography (HPLC) and liquid chromatography-mass spec-
trometry (LC/MS) to determine the concentrations of com-
pounds within trypanosomes. The compounds investigated,
which have the same core structure, do have several structural
modifications that could influence activity and DNA binding as
well as accumulation and distribution within trypanosomes.
Here we investigate two series of compounds, diphenyl furans
(including DB75) and aza analogs of diphenyl furans (includ-
ing DB820), to determine whether any correlation exists be-
tween trypanosome accumulation and intracellular distribution
and in vitro activity.
MATERIALS AND METHODS
Antitrypanosomal diamidines. Diamidine compounds were synthesized as
previously described (3, 7, 16, 20). Stock solutions of the compounds were
prepared at a concentration of 1 mM in sterile distilled water.
In vitro antitrypanosomal activity. To determine 50% inhibitory concentra-
tions (IC50 values), T. b. brucei S427 and T. b. rhodesiense STIB900 trypanosomes
(2  104 per ml) were cultured at 37°C and 5% CO2 with serial dilutions of the
diamidines for 72 h, using a previously described method (26). The T. b. brucei
strain S427 is routinely used at the University of North Carolina (UNC) for in
vitro activity, compound accumulation, and intracellular distribution studies. The
T. b. rhodesiense strain STIB900 is routinely used at the Swiss Tropical Institute
for screening diamidine compounds for both in vitro and in vivo activity (15).
Experiments were performed in triplicate with each trypanosome strain. IC50
values were determined using the Hill equation and are reported as averages for
at least three determinations.
DNA binding by thermal melting. Thermal melting experiments were con-
ducted with a Cary 300 Bio UV-visible spectrophotometer (Walnut Creek, CA)
as previously described (35). DNA samples for melting studies were added to 1
ml of MES buffer (0.01 M morpholineethanesulfonic acid [MES], 0.1 M NaCl,
0.001 M EDTA, pH 6.2) in 1-cm-path-length reduced-volume quartz cells. Ex-
periments were generally conducted at a concentration of 5  105 M in base
pairs for poly(dA)  poly(dT) or 1  106 M in duplex for the self-complemen-
tary oligomer d(CGCGAATTCGCG)2 (The Midland Certified Reagent Com-
pany, Inc., Midland, TX), which has a single AT binding site for the diamidines.
The concentration of DNA was determined by measuring the absorbance at 260
nm. For the diamidine-DNA complexes, a ratio of compound to DNA oligomer
duplex of 1:1 or a ratio of compound to DNA base pairs with poly(dA)  poly(dT)
of 0.6 was used. A thermistor fixed into a reference cuvette was used to monitor
the temperature, and the heating rate was 0.5°C/min. The data were collected as
absorbance (A) versus temperature (T) by a computer which also controlled the
instrument. The melting temperature (Tm) values for DNA alone or for the
complex of DNA and compound were determined by first-derivative analysis
(plot of A/T versus T), where the maximum marks the Tm at the inflection
point in the sigmoidal melting curve (A versus T; Tm  Tm for complex  Tm
for DNA).
Fluorescence spectra of diamidines in aqueous solution. Fluorescence scans to
determine excitation and emission maxima were performed using a Perkin-
Elmer luminescence spectrophotometer (LS 50B) using FL Winlab, version
4.00.02, software (Perkin-Elmer, Wellesley, MA). Compounds were prepared as
500 nM solutions in distilled water. One milliliter of each solution was trans-
ferred to a disposable cuvette (Fisher Scientific), and the fluorescence spectrum
was determined. Fluorescence intensity measurements were then determined
using the ex and em maxima.
For some compounds, the fluorescence properties were determined in the
presence of DNA. Briefly, fluorescence emission spectra were obtained with a
Cary Eclipse spectrofluorometer with software provided to control the instru-
ment and collect the fluorescence data. Typically, the fluorescence intensity for
a compound at a concentration of 1 M was measured at 25°C in MES buffer.
Compounds were excited at their maximum excitation wavelength, determined as
described above, and fluorescence emission spectra were collected. A solution of
each compound was titrated with aliquots of a stock solution of Clostridium
FIG. 1. Structures of diphenyl furan diamidines, presented in order of IC50 values against T. b. brucei S427 trypanosomes. DB75, which is shown
in bold, represents the prototypical diamidine in this series. All other compounds are modifications of DB75.
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perfringens genomic DNA (Sigma) containing 72% AT base pairs, and the sam-
ples were rescanned for emission spectra.
In vitro accumulation of diamidines in S427 trypanosomes. To determine the
in vitro accumulation of diamidines within trypanosomes over time, approxi-
mately 106 trypanosomes were incubated with a 7.5 M concentration of each
diamidine for periods ranging from 1 to 8 h. At each time point, trypanosomes
were washed twice in fresh drug-free medium, lysed, and extracted in 4 volumes
of 8:1 methanol–0.1 N HCl (vol/vol). Half of each sample was evaporated in a
Zymark (Hopkinton, MA) Turbovap-LV instrument under nitrogen gas (7 lb/
in2) and reconstituted in HPLC solvent A (described in detail in “HPLC analysis
of diamidines”). The remainder of the sample was retained for future analysis if
needed. Diamidine concentrations in trypanosomes were determined as de-
scribed previously (24).
In vitro distribution of diamidines in S427 trypanosomes. S427 trypanosomes
were cultured in 24-well plates (Corning Costar, Fisher Scientific) at a starting
concentration of 105 trypanosomes/ml. Diamidines were added to each well to a
final concentration of 500 nM. Trypanosomes were incubated with the diami-
dines for 8 h at 37°C, and then trypanosomes were examined under a light
microscope for motility and viability. Trypanosomes were washed twice in 1 ml
fresh medium which contained no diamidine and resuspended in 20 l of freshly
isolated mouse blood. A small drop of blood was placed on a microscope slide,
and thin films were prepared. Thin films were used to reduce the photobleaching
that occurs when viewing live trypanosomes under a UV-fluorescence cube. No
differences in intracellular distribution of fluorescence were seen when live
trypanosomes were viewed under fluorescent light.
Fluorescence microscopy of diamidines in trypanosomes. Thin films were
mounted with a drop of glycerol before observation. A Nikon Microphot FXA
microscope (Garden City, NJ) with a 60-DM 1.4-numerical-aperture objective
lens, a mercury lamp, and an Optronics DEI 750 charge-coupled device camera
(Goleta, CA) was used for fluorescence microscopy. The microscope was
equipped with a Nikon UV2A cube that limits excitation wavelengths to 330 to
380 nm and emission wavelengths to 420 nm. The UV2A cube allows for the
visualization of the blue fluorescence seen in the nucleus and kinetoplast and the
yellow/orange fluorescence seen in the acidocalcisomes due to interactions of
diamidines with polyphosphates in these organelles (31).
Distribution of DB75 in acidocalcisomes. Trypanosoma brucei brucei S427
trypanosomes were cultured in CBMEM as previously described (24). For var-
ious time points from 5 min to 1 h, 106 trypanosomes were pretreated with a
stock solution of 5 M monensin (Sigma) prepared in ethanol or 20 mM am-
monium chloride. After pretreatment, trypanosomes were washed and then
DB75 was added to a final concentration of 7.5 M. DB75 was incubated with
trypanosomes for 2 h, and then trypanosomes were washed twice and resus-
pended in freshly isolated mouse blood (20 l). Thin films were prepared from
a drop of blood and viewed with a Nikon Microphot FXA microscope equipped
with a 60-DM 1.4-numerical-aperture objective lens, a mercury lamp, and a
QImaging Micropublisher 3.3 charge-coupled device digital camera (QImaging
Corporation, Surrey, British Columbia, Canada) for fluorescence microscopy.
QCapture, version 3.0, imaging software was used to capture images (QImaging
Corporation). The microscope was equipped with a Nikon UV2A cube that
limits excitation wavelengths to 330 to 380 nm and emission wavelengths to 420
nm. Acridine orange (Sigma) was also used as a marker for acidocalcisome
accumulation. Acridine orange has been shown in the past to accumulate in
acidocalcisomes and to be displaced by alkalinizing agents (12).
HPLC analysis of diamidines. HPLC analytical methods for DB1017, DB244,
DB249, DB103, DB60, DB935, and DB829 were based on analytical methods
previously described for DB75 and DB820 (24, 30). HPLC solvent A consisted of
15 mM ammonium formate, 30 mM formic acid in HPLC-grade water, while
solvent B contained the same buffer system prepared in 4:1 acetonitrile–HPLC-
grade water. An elution gradient was used to resolve each diamidine, with
starting conditions of 95% solvent A and 5% solvent B, which increased linearly
over 10 to 15 min, followed by a 3- to 5-min reequilibration to starting conditions.
An Agilent Zorbax Bonus RP (New Castle, DE) column (2.1 mm by 50 mm; 3.5
m) was used for compound resolution. Compounds were detected using their
maximum excitation and emission wavelengths (see Table 3).
MS analysis of diamidines. DB690, DB867, DB1057, and DB879 concentra-
tions were determined by LC/MS. To verify results, analyses of DB103 and DB60
were conducted via HPLC with fluorescence detection as well as via LC/MS.
Depending on the molecular weight of the test diamidine, either DB75 or DB103
was used as an internal standard. Automated sample analysis was performed
using Analyst software (version 1.4.1; Applied Biosystems, Foster City, CA). The
Analyst-controlled HPLC-MS/MS system consisted of two Shimadzu Scientific
(Columbia, MD) solvent delivery pumps, a thermostated (6°C) LEAP HTC
autosampler (Carrboro, NC), and an Applied Biosystems API4000 triple-qua-
drupole mass spectrometer. Reversed-phase gradient chromatography was used
to elute the diamidines from an Aquasil (C18; 5 m; 50 mm by 2.1 mm) analytical
column (Torrance, CA) at a flow rate of 0.75 ml/min, following injection of 4-l
sample. Starting conditions for each injection were 95%–5% water-methanol,
with 0.1% formic acid (vol/vol) in each. The relative amounts of water and
methanol were held constant for 0.5 min while the column eluted to waste. After
0.5 min, the eluent was directed to the mass spectrometer, and the relative
amount of methanol was increased linearly to 90% at 3 min postinjection. This
amount of methanol was held for 0.5 min to wash the column. The column was
reequilibrated under the starting conditions for the final 0.5 min. Total run time
was 4 min. The mass spectrometer was connected to the HPLC system by a
Turbo ion spray interface. Nitrogen from a Peak Scientific (Bedford, MA)
nitrogen generator was used as the curtain, nebulizer, and collision gas. User-
controlled voltages, gas pressures, and source temperature were optimized for
the detection of the parent and product ions of the diamidines. All diamidines
were analyzed in positive-ion mode, using multiple reaction monitoring.
RESULTS
In vitro antitrypanosomal activity of diamidines. Two series
of diamidines were investigated, namely, the diphenyl furan
series, which includes DB75, and the aza analogs, which in-
clude DB820 (Fig. 1 and 2). Compounds in the diphenyl furan
series had the greatest structural diversity, with modifications
to the core structure, N substitutions on the diamidines, and
cyclic diamidines. Compounds in the aza series had less struc-
tural diversity, with modifications to the core structure only.
All compounds were active in vitro, although activities against
T. b. brucei S427 and T. b. rhodesiense STIB900 varied greatly
(Tables 1 and 2).
The majority of the diamidines used in this study have two
positive charges at physiological pH (pH 7.0) and lower pH val-
ues. pKa values for DB75, for example, have been determined to
be around pH 11 (Table 1). Calculated logD and calculated pKa
values, obtained from ChemAxon MarvinSketch, are shown in
Tables 1 and 2 for both series of compounds. ChemAxon’s pro-
gram calculated values consistent with measured values. This pro-
gram was a better predictor than was ACD LogD Suite v 4.5
(Advanced Chemistry Development, Inc., Toronto, Canada). As
seen in Tables 1 and 2, pKa values for all the diamidines are
approximately 10 or greater, indicating that the compounds will
be doubly charged at physiological pH. Most compounds, with the
exception of DB244 and DB249, are hydrophilic at pH 7.4.
DB244 and DB249 are both slightly lipophilic at this pH, likely
FIG. 2. Structures of the aza analog diamidines, presented in order
of IC50 values against T. b. brucei S427 trypanosomes. DB820, which is
shown in bold, represents the prototypical diamidine in this series. All
other compounds are modifications of DB820.
VOL. 51, 2007 ACCUMULATION OF DIAMIDINES IN TRYPANOSOMES 2803
due to the substitution of bulky cyclic groups off the diamidines,
which could mask the positive charges.
(i) Diphenyl furans. Diamidines in the diphenyl furan series
had IC50 values ranging between 2 and 260 nM, a 100-fold
difference in activity, against the S427 strain (Table 1). The
three compounds with unmodified diamidines (DB690, DB75,
and DB1017) were the most potent. Changes in bond position-
ing (DB690) or the addition of functional groups to the core
nucleus (DB1017) had only a modest (two- to threefold) effect
on activity compared to that of DB75. Compounds which had
substituted amidines (DB244 and DB249) had intermediate
potency against S427 trypanosomes, with IC50 values of 100 to
150 nM. The cyclic diamidines, the imidazoline DB60, and the
tetrahydropyrimidyl DB103 were the least potent compounds
in this series against S427 trypanosomes. Against the STIB900
strain, the trend in activity for diphenyl furans was similar to
that for the S427 strain, with six of the seven compounds
having the same rank order against both strains (Table 1). The
only exception was DB103, which had an IC50 value of over 100
nM for the S427 strain but was much more active against the
STIB900 strain (IC50 value of 33 nM).
(ii) Aza analogs. All aza analogs had unmodified amidine
moieties. Five of the six compounds were potent, with activities
against T. b. brucei S427 varying only 10-fold (Table 2). DB867
was the most potent compound, with an IC50 value of 3.3 nM.
The positioning of the nitrogen in the aromatic rings had only
minor effects (DB867, DB820, and DB829). As with the di-
phenyl furans, there was little impact on activity when func-
tional groups were added to the aromatic rings (DB935 and
DB1057). Between DB867 and DB1057, there was only a 10-
fold difference in IC50 values. DB879, which has a methylene
group inserted between the furan and phenyl rings, was much
less potent than the other compounds in this series. IC50 values
for the compounds in this series against the STIB900 strain
were similar for all compounds and were in the same rank
order. DB879 was about twofold more potent against STIB900
trypanosomes than against S427 trypanosomes but overall was
still not a very potent compound.
Thermal melting analysis of DNA binding. Increases in Tm
values for compound-DNA oligomer and compound-polymer
complexes are shown in Tables 1 and 2. The majority of the
compounds in these two series were potent DNA binders and
bound strongly to both poly(dA)  poly(dT), which has multi-
ple AT binding sites, and the d(CGCGAATTCGCG) oligomer
duplex, which has a single AT binding site for diamidines
(Tables 1 and 2). Studies with a wide array of diamidines have
shown that evaluation of increases in the melting temperature
of DNA upon addition of the compounds provides a rapid
method for ranking diamidines according to their binding af-
finities (23).
All of the diphenyl furans were potent binders, with Tm
values of 15°C for poly(dA)  poly(dT) and 8°C for the
d(CGCGAATTCGCG) oligomer duplex. The largest in-
creases in the melting temperature were seen with DB244,
DB249, DB103, and DB75 (Table 1), but there was no corre-
lation between activity of the diphenyl furans and DNA bind-
ing affinity (r2  0.09). With the aza analogs (Table 2), there
appeared to be a correlation between the activity and the
increase in melting temperature with the poly(dA)  poly(dT)
oligomer and the d(CGCGAATTCGCG) oligomer duplex
(r2  0.9; slope, 0.05 and 0.03, respectively), but this corre-
lation was driven by the low Tm values determined with
DB879. When DB879 is removed from the series, no correla-
tion exists (r2  0.4 and 0.03 for the two oligomers, respec-
tively). DB879, the least potent compound investigated, had
TABLE 1. In vitro activity and DNA binding (Tm) of select diphenyl furans
Compound pKa clogDa
IC50 value (nM) Tm
S427 STIB 900 Poly(dA)  poly(dT) (dCGCGAATTCGCG)2
DB690 10.8, 11.6 2.8 2.1 1.7 17.1 10.4
DB75 10.4, 11.8 2.0 7 3.2 26.2 8.9
DB1017 10.5, 11.3 1.2 14.8 8.0 15.2 8.2
DB244 10.3, 11.1 0.2 100 60 27 16
DB249 10.3, 11.1 1.0 121 68 27 16.8
DB60 8.8, 9.5 0.4 251 245 19.3 11.0
DB103 9.5, 10.2 1.3 260 33 27 15.1
a clogD values (at pH 7.4) and pKa values were calculated using ChemAxon MarvinSketch. DB75 and DB1017 pKa and logD values were measured by J. Saulter
(by a UV spectrophotometric method).
TABLE 2. In vitro activity and DNA binding (Tm) of select aza analogs
Compound pKa clogDa
IC50 value (nM) Tm
S427 STIB 900 Poly(dA)  poly(dT) (dCGCGAATTCGCG)2
DB867 8.5, 11.1 2.8 3.3 2.1 23.3 10.4
DB820 10.5, 11.8 3.8 3.4 6.5 20.0 11.2
DB935 9.9, 11.3 4.5 10 9.7 16.7 10.6
DB829 9.6, 10.3 3.3 13 19 16.0 8.4
DB1057 7.4, 11.6 2.7 32 32 16.4 10.4
DB879 9.9, 11.6 3.5 314 147 3.1 0.4
a clogD values (at pH 7.4) and pKa values were calculated using ChemAxon MarvinSketch.
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little effect on the melting temperature of the DNA complex
(Table 2).
Intracellular accumulation of diamidines in T. b. brucei
S427. DB75 and DB820 were previously shown to accumulate
to approximately 12 mM and 3 mM, respectively, after a 24-h
in vitro incubation with 7.5 M of either compound (24). Since
the compounds chosen for investigation have a wide range of
in vitro activities, we chose the concentration of 7.5 M to
incubate with trypanosomes for comparison to previous work.
After investigating the accumulation of several of the diami-
dines, the pattern of intracellular concentration was similar to
that reported previously (24). However, the toxicity of some of
the compounds became an issue with the accumulation exper-
iments (increasing cell death when incubated for longer than
8 h), so investigations were limited to 8 h.
Due to poor fluorescence intensity, some compounds were
analyzed and quantified by LC/MS instead of HPLC, which
was used for the more fluorescent compounds. DB75, DB1017,
DB244, DB249, DB103, DB60, DB935, DB820, and DB829
were analyzed using HPLC, while DB690, DB867, DB1057,
and DB879 were analyzed by LC/MS.
(i) Diphenyl furans. All of the diphenyl furans accumulated
to high concentrations, with peak concentrations ranging from
1 mM to 30 mM (Fig. 3), after 8 h of incubation at 7.5 M.
Three of the diphenyl furans (DB690, DB244, and DB249)
investigated accumulated to higher peak concentrations in try-
panosomes than those seen previously for DB75 (4.5 	 0.3 mM
at 8 h) (Fig. 3A). DB690, the most potent diphenyl furan
investigated, as well as DB244 and DB249, with intermediate
potencies, accumulated to peak concentrations of approxi-
mately 30 mM (Fig. 3A). The other diphenyl furans accumu-
lated in trypanosomes to peak concentrations similar to that of
DB75 (Fig. 3B). Thus, there appears to be no trend linking the
potency of the diamidines and accumulation of the diphenyl
furans in trypanosomes over time.
(ii) Aza analogs. Compounds in the aza analog series accu-
mulated linearly over 8 h in trypanosomes, for the most part
(Fig. 4), except for DB867, which accumulated in a nonlinear
manner. DB820 had a peak concentration of 1.0 	 0.2 mM at
8 h. DB867, the most potent compound in this series (Table 2),
which has the nitrogen in the pyrimidine ring moved meta- to
the furan ring, accumulated to a concentration of 9.3 	 2.0
mM after 8 h, which is significantly greater than the accumu-
lation of DB820. DB935, which has a methyl substituent on the
phenyl ring, accumulated to concentrations in trypanosomes
which were fourfold higher than that of DB820, despite being
threefold less potent. All compounds in the aza analog series
accumulated to higher concentrations than DB820, including
DB879, the least potent diamidine investigated, as seen in Fig. 4.
Fluorescence spectra of diamidines in aqueous solution.
The fluorescence spectra of diamidines were determined for
developing analysis methods and for the fluorescence micros-
copy studies. The fluorescence of the diamidines varied in
terms of intensity and excitation (ex) and emission (em)
wavelengths (Table 3).
(i) Diphenyl furans. In the diphenyl furan series, four com-
pounds had similar fluorescence spectra in water. DB75,
DB1017, DB244, and DB249 had excitation maxima around
355 nm, with maximum emission around 455 nm. Of these
compounds, DB249 had the highest emission intensity, and
DB75 had the lowest emission intensity. Other structural mod-
ifications to DB75 tended to shift either the excitation wave-
length, by about 20 nm (DB690 or DB60), or the emission
maximum, by 20 nm (DB103), in either direction. In addition
to shifting fluorescence spectra, some of the modifications also
greatly decreased the fluorescence intensity, as seen with
DB690 (Table 3).
The fluorescence properties of select diphenyl furan diami-
dines were also investigated in the presence of AT-rich DNA.
The fluorescence of DB690, which is only weakly fluorescent in
solution, increased almost 300% in the presence of DNA,
while the fluorescence of DB75 decreased 17% in the presence
FIG. 3. In vitro accumulation of diphenyl furans (7.5 M) over 8 h.
(A) Accumulation of diphenyl furans to concentrations much higher
than that of DB75. (B) Accumulation at lower millimolar levels over
8 h. Accumulation, which was determined by HPLC or LC/MS anal-
ysis, is presented as the mean concentration 	 standard error. Data for
DB569 are not shown, as it killed trypanosomes rapidly, and accumu-
lation was unable to be determined.
FIG. 4. In vitro accumulation of aza analogues (7.5 M) over 8 h.
Data are presented as mean concentrations 	 standard errors. Accu-
mulation was determined by HPLC or LC/MS analysis.
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of DNA (Table 3). The fluorescence intensity of DB60 also
decreased 23% when bound to DNA.
(ii) Aza analogs. In the aza series, only DB820 and DB935
had similar excitation and emission spectra, with a maximum
excitation wavelength of about 360 nm and emission around
460 nm. The spectra of other compounds were shifted in either
the excitation or emission wavelength or both. Placing the
nitrogen in the pyrimidine ring ortho- to the amidine (DB867),
as opposed to meta- to the amidine (DB820), shifted the exci-
tation maximum 10 nm, and the emission maximum was also
shifted 20 nm. This modification also decreased the fluores-
cence intensity approximately 60-fold. However, having two
nitrogens—one in each pyrimidine ring (DB867)—increased
the fluorescence intensity twofold over that of DB820 while
shifting the maximum emission wavelength down 20 nm. The
addition of either an alcohol group to the phenyl ring or a
methylene linker between the phenyl and furan ring decreased
the fluorescence intensity dramatically (Table 3).
The fluorescence of select diamidines was investigated in the
presence of AT-rich DNA. As with DB690 in the diphenyl
furan series, the fluorescence of the weakly fluorescent DB867
analog was greatly enhanced (almost 400%) with increasing
concentrations of DNA (Table 3). The very fluorescent DB820
and DB829 molecules exhibited decreased fluorescence when
bound to DNA (50% and 86%, respectively).
Intracellular distribution of diamidines in T. b. brucei S427.
The majority of the compounds in both series were distributed
in the following three organelles in the trypanosomes: the
kinetoplast, the nucleus, and the acidocalcisomes (see below).
A concentration of 500 nM was chosen for microscopy studies
for several reasons, including prevention of fluorescence signal
saturation of the compounds and the toxicity of some com-
pounds at higher concentrations. For some compounds that
were less fluorescent, distribution at 5 M was also investi-
gated, but no difference in the fluorescence intensity within
trypanosomes was identified.
(i) DB75 localization to the acidocalcisomes. After a 2-hour
incubation in vitro with S427 trypanosomes, DB75 accumu-
lated in the nucleus, kinetoplast, and acidocalcisomes (Fig. 5,
first column). However, when ammonium chloride or monen-
sin was used as a pretreatment before DB75 was added, accu-
mulation in the acidocalcisomes was not seen (Fig. 5, columns
2 and 3). A 60-min pretreatment of ammonium chloride was
needed to prevent DB75 accumulation in acidocalcisomes, al-
though partial inhibition of acidocalcisome localization was
seen after 30 min. The sodium ionophore monensin, on the
other hand, needed to be incubated with trypanosomes for
only 15 min before DB75 was added to abolish acidocalcisome
accumulation. Partial inhibition of accumulation was seen after
5 min. Additionally, monensin prevented acridine orange flu-
orescence in the acidocalcisomes of trypanosomes after only 15
min (data not shown). We were unable to use fixation and
colocalization techniques due to issues with redistribution of
DB75 or loss of fluorescence (30).
(ii) Diphenyl furans. DB75 accumulated in the nucleus,
kinetoplast, and acidocalcisomes after 8 h of in vitro incubation
(Fig. 6). There were four compounds in the diphenyl furan
series that had similar fluorescence spectra and relatively sim-
ilar fluorescence intensities, namely, DB75, DB1017, DB244,
and DB249. Compounds with similar fluorescence properties
can be compared directly, but it must be considered that each
compound may behave differently when accumulated in cells
(i.e., fluorescence could be shifted, enhanced, or quenched
upon sequestration in organelles, and this may be different for
each compound). Like DB75, DB1017 appeared to be local-
ized to the kinetoplast, nucleus, and acidocalcisomes (based on
comparison of localization between DB75 and DB1017). The
color shift in the acidocalcisomes with this compound was
more orange, in contrast to the yellow seen in DB75-stained
acidocalcisomes. DB244 and DB249 were both found only in
the nucleus and kinetoplast (Fig. 6).
For the rest of the diphenyl furans, the excitation and/or
emission wavelengths were shifted slightly, and no direct com-
parisons can be made as to their relative fluorescence intensi-
ties. DB690 appeared to accumulate only in the kinetoplast, as
shown in Fig. 6. However, due to the weak innate fluorescence
of DB690 (Table 3), it is possible that there was some low-level
fluorescence in other organelles in the trypanosomes which we
were unable to observe. Additionally, the peak excitation of
DB690 is below the limit of detection of the UV2A cube, and
we likely did not see the compound excited at its maximal
excitation wavelength. The imidazoline DB60 was localized to
the kinetoplast, nucleus, and acidocalcisomes. DB103 accumu-
lated only in the nucleus and the kinetoplast (Fig. 6).
FIG. 5. Distribution of DB75 (7.5 M) in trypanosomes alone (first
column) and after either a 60-min pretreatment of ammonium chlo-
ride (NH4Cl) or a 15-min pretreatment of monensin.
TABLE 3. Fluorescence properties of aqueous solutions (500 nM)
of diphenyl furan and aza analogs and changes in fluorescence of
select analogs bound to DNA







DB690 323 452 51 1270
DB75 356 458 464 217
DB1017 354 455 840 ND
DB244 356 450 625 ND
DB249 356 453 920 ND
DB60 373 458 630 223
DB103 352 437 860 ND
DB867 370 481 51 1360
DB820 359 455 318 250
DB935 358 461 330 ND
DB829 359 433 701 286
DB1057 352 470 16 ND
DB879 337 435 17 ND
a Determined at a concentration of 1 M. ND, not determined.
2806 MATHIS ET AL. ANTIMICROB. AGENTS CHEMOTHER.
(iii) Aza analogs. DB820, as shown previously, was localized
to the nucleus, kinetoplast, and (faintly) the acidocalcisomes
(Fig. 7). DB935, the only compound with similar excitation and
emission wavelengths to those of DB820, was localized to the
nucleus and kinetoplast. The most potent analog, DB867, ap-
peared in the nucleus, kinetoplast, and acidocalcisomes (Fig.
7). Despite being weakly fluorescent in solution, the compound
exhibited intense fluorescence in trypanosomes, which may be
related to an increase in fluorescence when bound to DNA
(Table 3). DB1057 was found in the nucleus and kinetoplast,
while DB829 was found in the nucleus, kinetoplast, and acidocal-
cisomes. DB879, the least potent of the DB820 analogs, was
located very faintly in the kinetoplast. The compound is weakly
fluorescent, which may affect the appearance of fluorescence seen
in the trypanosome, although DB879 concentrated in trypano-
somes to levels comparable to those of the other aza analogs.
DISCUSSION
Diphenyl furan and aza diphenyl furan diamidines represent
two potent classes of antitrypanosomal compounds. The com-
pounds shown here had a 150-fold range of in vitro activities,
and some had different organelle distributions within the cells.
However, despite the wide range of activities and distributions
and, for the most part, similar DNA binding properties, the
FIG. 6. Fluorescence microscopy of the diphenyl furans (listed in
order of IC50 values) at 8 h following incubation with 500 nM of each
compound. Images at the top depict phase-contrast images of try-
panosomes, while those at the bottom are fluorescence images of
the same trypanosomes. Arrows, nucleus; circles, kinetoplast; ar-
rowheads, acidocalcisomes.
FIG. 7. Fluorescence microscopy of the aza analogs (listed in order of
IC50 values) at 8 h following incubation with 500 nM of each compound.
Images at the top depict phase-contrast images of trypanosomes, while
those at the bottom are fluorescence images of the same trypanosomes.
Arrows, nucleus; circles, kinetoplast; arrowheads, acidocalcisomes.
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compounds accumulated to similar concentrations in the cells,
with only a few exceptions.
Eight compounds in the diphenyl furan series were investi-
gated. The substituted and cyclic diamidines were the least
potent compounds in this series, and the fact that modification
to the diamidine affected their potency reinforces the impor-
tance of the moiety in the potential mechanism of action of
these compounds. Other modifications of DB75 had little ef-
fect on the IC50 value, changing potency only approximately
twofold.
In the aza analog series, the only modification to have a
major effect on potency was the methylene linker in DB879,
which also decreased DNA binding, likely due to the change in
curvature of the molecule. This illustrates the importance of a
threshold DNA binding activity necessary for antitrypanoso-
mal activity of these compounds.
DNA binding for the two series of compounds, as deter-
mined by measuring the Tm in the presence of compound,
was similar for most of the compounds. With the exception of
DB879, all of the compounds tested increased the melting
temperature of a poly(dA)  poly(dT) complex 15°C. With
DB879, the methylene linker appeared to inhibit DNA bind-
ing. Surprisingly, differing effects were seen when the fluores-
cence of select diamidines was measured when the compounds
were bound to DNA. The least fluorescent analogs, DB690 and
DB867, exhibited increased fluorescence when bound to AT-
rich DNA, while more fluorescent analogs had decreased flu-
orescence when bound to DNA. The DNA used for this ex-
periment was chosen because of its high AT content. However,
conclusions about changes in fluorescence in the trypanosome
organelles cannot be made until they are measured with iso-
lated kinetoplast and nuclear DNA.
We previously proposed (34) that interaction with DNA
alone was insufficient to generate biological activity. In one
possible mechanism for biological activity of the dications,
however, DNA binding would be an initial requirement but
specific secondary effects, which occur subsequent to binding,
would be required for activity. Such effects could be topolog-
ical changes induced in DNA as a result of binding that cause
errors in DNA structure, with resulting instability and eventual
destruction. It is also possible that binding could result in
direct inhibition of DNA-targeted enzymes or control proteins,
which could also lead to cell death. These secondary effects
could vary significantly among compounds with similar binding
affinities for DNA and could account for the different activities
of compounds with similar uptake rates and DNA affinities.
The set of compounds in this paper that have similar DNA
binding and uptake would make an excellent test set for testing
the possible influence of secondary effects, after DNA binding,
on biological activity.
Changes to the structure of the compounds also resulted in
changes in the accumulation of the compounds in trypano-
somes. Surprisingly, some of the more potent compounds, in-
cluding DB75 and DB820, accumulated to lesser extents than
did some less active compounds, such as DB244 and DB249.
Additionally, in the aza analog series, all of the compounds
investigated accumulated to higher concentrations in trypano-
somes than that of the very potent compound DB820 (Fig. 4).
There also does not appear to be any correlation between
which organelles the compounds are distributed to and overall
accumulation in trypanosomes. For example, DB820, one of
the most potent compounds examined, had the lowest accu-
mulation in trypanosomes. Of the three compounds that accu-
mulated to the highest concentrations in trypanosomes, one
appeared to be localized to the kinetoplast only (DB690),
while the other two were localized to the nucleus and kineto-
plast (DB244 and DB249). DB690 was the most potent of the
compounds tested, while DB244 and DB249 had intermediate
IC50 values, yet all three accumulated to similar concentrations
in trypanosomes. However, as stated previously, DB690 is a
weakly fluorescent compound with a peak excitation wave-
length below the limit of detection of the UV2A cube used for
fluorescence microscopy. It is thus possible that we did not see
the true distribution of DB690 in trypanosomes, even account-
ing for the enhancement of DB690 fluorescence when it was
bound to AT-rich DNA (Table 3). This indicates that neither
concentration nor distribution in trypanosomes can be pre-
dicted from in vitro activity. Additionally, the site of localiza-
tion in trypanosomes cannot be predicted from the accumula-
tion in the cells, or vice versa.
It is likely from these series of diamidines that DNA binding
in either the nucleus or kinetoplast is important, especially
considering that, for the most part, all of these compounds are
excellent DNA binders. Further studies are needed to deter-
mine relative amounts of diamidines in each organelle as well
as relative affinities for DNA-associated proteins found in ei-
ther or both organelles. Only then can organelle-specific mech-
anisms of action be determined. Additionally, changes in flu-
orescence intensity and/or shifts in excitation or emission
wavelengths may occur when compounds bind DNA, as shown
in Table 3. Although the DNA used for that investigation was
AT-rich, to be certain of relative fluorescence changes in the
nucleus or kinetoplast, DNAs from both organelles must be
isolated and binding and fluorescence changes measured. With
the dramatic changes seen here, these measurements should
be determined routinely in the future in order to extrapolate
from DNA binding to distribution studies.
Tools used for investigating the transport and uptake of
compounds in trypanosomes include rapid transport experi-
ments with various inhibitors that prevent uptake via particular
transporters. Transport of diamidines has been attributed to
uptake via the P2 transporter (5, 8, 22, 29), and in the case of
pentamidine, HAPT1 and LAPT1 are also involved in uptake
and accumulation (4). Lanteri et al. were able to inhibit uptake
of DB75 for 30 s with inhibitors of the P2 transporter, such as
adenosine, adenine, pentamidine, and diminazene (21, 22),
indicating that it is likely a substrate of the P2 transporter.
However, transport studies with all of the compounds investi-
gated here have not been implemented, and further investiga-
tion is needed to determine the impact of transporters on
long-term accumulation. The high levels of DB690, DB244,
and DB249 in trypanosomes may indicate that others trans-
porters or transport processes are involved in the uptake of
these compounds.
The effects of endogenous substrates of the transporters,
such as adenosine, can be assayed in vitro in antitrypanosomal
activity experiments to determine if the presence of other sub-
strates affects the potency (i.e., increases the IC50 value) of the
test compounds (13). When an IC50 value was determined for
DB75 in the presence of 1 mM adenosine (a substrate of the P1
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and P2 transporters), we found that the IC50 value increased
10-fold over that of controls without adenosine (data not
shown). However, there was no effect seen in the presence of
inosine, a substrate for the P1 transporter. This phenomenon
has also been shown with the adenosine antimetabolite tuber-
cidin in trypanosomes, where the addition of 1 mM adenosine
or inosine decreased the antitrypanosomal IC50 value of tuber-
cidin four- to fivefold (13). The decrease in potency of DB75 in
the presence of excess adenosine is likely due to less DB75
getting into trypanosomes, but this should be evaluated further
over time to determine if there is a significant reduction in the
amount of DB75 accumulating in the trypanosomes.
Additionally, the impact of increasing the lipophilicity of
compounds such as DB244 and DB249 on the transport prop-
erties should be investigated further. It is possible that other
transporters or uptake processes are involved in the accumu-
lation of the more lipophilic compounds. Is it possible that
these compounds are accumulated by both passive diffusion
and active transport? Both DB244 and DB249, according to
calculations performed using ChemAxon MarvinSketch, are
lipophilic at physiological pH (pH 7.4) and could potentially
diffuse across trypanosome membranes.
We also attempted to investigate the accumulation and dis-
tribution of another compound in the diphenyl furan series,
DB569. DB569 is an N-phenyl-substituted diamidine. In cancer
cells, DB569 was found to be localized to the mitochondria
instead of the nucleus (20). However, this compound was rap-
idly toxic to trypanosomes, inducing cell death in 1 h. At lower
concentrations, the substituted diamidine appeared to be
widely distributed throughout trypanosomes (data not shown).
Increased lipophilicity could be one reason that DB569 rapidly
kills trypanosomes, due to high levels accumulating in trypano-
somes. The pKa of DB569 was determined to occur at pH 6.9
(average) (data not shown), indicating that at the pH of the
medium (pH 7.4), over one-half of the drug was un-ionized, in
contrast to 
1% un-ionized drug with DB75, which has a pKa
of around 11. The logD of DB569 at pH 7.4 was calculated to
be 5.1 using ChemAxon MarvinSketch, indicating that the sub-
stituted diamidine is highly lipophilic at this pH and would
likely diffuse across cell membranes more rapidly than unsub-
stituted diamidines. DB569 is an interesting diamidine, as it
has very different physicochemical properties from those of
other diamidines we have examined. Additionally, due to its
rapid killing of trypanosomes, it may have different mecha-
nisms of action. It is clear that more than one approach is
needed to fully characterize the processes of transport and
accumulation of diamidines in trypanosomes. One interesting
avenue would be to investigate the long-term accumulation of
diamidines in trypanosomes that lack the P2 transporter.
All of the compounds investigated in both series of diami-
dines were found in the nucleus, the kinetoplast, or both. A few
of the compounds, with various potencies, also accumulated in
the acidocalcisomes. Due to previous evidence to support
DNA binding as a mechanism of action, primarily studied with
pentamidine (27, 28), our original hypothesis when we began
working with DB75 and DB820 was that their mechanism of
action would be related to DNA binding as well. It is still not
understood what impact the acidocalcisomes could have on the
mechanism of action. It may be that even for this closely
related group of compounds, there could potentially be two or
three mechanisms of action, involving DNA in the nucleus and
kinetoplast as well as some mechanism in the acidocalcisomes.
As dicationic molecules, the diamidines may accumulate in the
low-pH acidocalcisomes and interfere with homeostasis mech-
anisms in trypanosomes.
Many questions still remain about the mechanisms of action
of these compounds. The lack of correlation between accumu-
lation and activity of the compounds is intriguing. Why do
some of the less active compounds accumulate to levels much
higher than those of the more active compounds? There is also
likely a time dependency to the amount of drug that is neces-
sary to kill trypanosomes.
Investigations with DB569, DB75, and DB820 indicated that
only about 30 min to 1 h of drug treatment is necessary to cause
trypanosome death. With DB75 and DB820, death occurred 24
to 48 h after washing away the drug (data not shown), but with
DB569, death occurred within 1 h, which may indicate a dif-
ferent mechanism of action from that of DB75 and DB820.
DB569 has also been shown to cause apoptosis in Trypanosoma
cruzi, to a greater extent than DB75 (10). However, no indi-
cation of the time which this process needs to take place was
indicated. In vivo, DB569 resulted in increased survival of mice
infected with T. cruzi and in decreased cardiac parasitism but
was unable to clear parasitemia (11). Since we were unable to
investigate the accumulation of DB569 in our trypanosomes,
we cannot compare it completely to other substituted diami-
dines, such as DB244 and DB249. However, the differences in
killing seen between DB569 and the other compounds in this
series are very intriguing and require further investigation,
especially since DB569 would appear to not be very potent in
a typical in vitro screen for antitrypanosomal activity and in
light of its different physicochemical properties.
In summary, the accumulation and distribution of a diphenyl
furan or an aza analog in trypanosomes are not indicative of its
antitrypanosomal activity. In actuality, there may be a mini-
mum in vitro accumulation of a diamidine in trypanosomes
necessary for killing. From this study, it seems that a minimum
accumulation concentration of 1 mM in trypanosomes is nec-
essary for this type of compound. DB820, the compound that
accumulated the least in trypanosomes, was also one of the
most potent compounds. Whether this minimum accumulation
level would hold true for other series of diamidines remains to
be investigated. The overall accumulation level depends on a
variety of factors, including which transporters play a role in
accumulation and the relative affinities for the transporters.
The factors that affect transport, accumulation, and ultimately
the mechanism of action will be investigated further using this
series of diamidines as well as other, more structurally diverse
diamidines.
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